Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human FGF-12 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Supplier: R&D Systems™ 2246FG025/CF
This item is not returnable.
View return policy
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human FGFR4 Fc Chimera (Catalog # 685-FR ) is immobilized at 2 μg/mL, 100 μL/well, Recombinant FGF-12 binds with an ED50 of 3-18 μg/mL.Specifications
NP_004104 | |
Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4 and EDTA. | |
M.W. (theoretical): 20.4 kDa | |
25 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
FGF12 | |
Recombinant | |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Bioactivity | |
2257 | |
FGF-12 | |
E. coli-derived human FGF-12 protein Met1-Thr181 | |
<0.10 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 100 μg/mL in sterile PBS. | |
FGF-12 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction